ACR24 - PSORIATIC ARTHRITIS

A New ACRApremilast Benefits and Risks in PsABest Things I Saw Today in PsABimekizumab in PsA Showed Sustained Reductions in Disease ImpactBiologic Monotherapy vs Combination with cDMARDs in PsADo TNFis and JAKis Prevent Cancer!?Improvements in Pain and Fatigue in BimekizumabLong-term Safety Profile of Bimekizumab in axSpA and PsAPotential Impact of Weight Loss Drugs in Rheumatic DiseasesProposed ACR Guidance for Use of MSUS in Psoriatic ArthritisPsA PotpourriPsA Ultrasound UpdatesPsA: Impact of SexSex Differences in Psoriatic ArthritisThe Psoriatic March: PsA before PsOApremilast in PsA: Results from Mosaic TrialAnti IL-17 on Entheseal Biopsy in PsA